Related Experiment Video
Updated: Aug 15, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
Recombinant yeast as a vaccine vector for the induction of cytotoxic T-lymphocyte responses
Andrew C Stubbs1, Cara C Wilson
1Department of Medicine, University of Colorado Health Sciences Center, Denver 80262, USA. andrew.stubbs@uchsc.edu
Abstract:
There is currently a need to develop safe and effective vaccines for the induction of cellular, in particular cytotoxic T-lymphocyte-mediated, protective immune responses. This review focuses on the challenges presented by such an endeavor, current strategies for the induction of such responses, and the relatively new idea that recombinant yeast may represent an ideal vaccine vector for the induction of cellular immune responses.
Related Concept Videos
Vaccinations
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

